NEW YORK, Jan. 26, 2022 /PRNewswire/ -- The demand for molecular biology enzymes, kits, and reagents is increasing continuously among end-users. Hospitals, diagnostic centers, academic institutes, and research organizations extensively use molecular biology kits that include enzymes and reagents for disease diagnosis.
The advent of molecular technologies and the development of genomics have significantly increased the demand for molecular biology consumables at the genomic level. Also, the increasing use of molecular biology kits in the identification of disease-related genes and management of infectious diseases will positively influence market growth.
To understand more about Market Dynamics. Download our FREE sample report
Key Molecular Biology Enzymes, Kits, and Reagents Market Report Highlights:
Regional Market Analysis
With 39% of the growth originating from North America, this region will record a faster growth rate during 2020-2025.
The presence of a large number of players and increasing investments in the field of biotechnology are driving the growth of the molecular biology enzymes, kits, and reagents market in North America. The market growth in the region will be slower than the growth of the market in Asia. The US is the key market for molecular biology enzymes, kits, and reagents in North America.
For Additional Information about the regional market: Request for a free sample report.
Key Vendors and Vendor Strategies
Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc. are some of the dominant players in the molecular biology enzymes, kits, and reagents market.
The molecular biology enzymes, kits, and reagents market is fragmented due to the presence of a large number of players. The vendors in the market are constantly adopting various organic and inorganic growth strategies to remain competitive in the market. Some vendors are focusing on forming strategic alliances or acquiring other players in the market to remain competitive.
Agilent Technologies Inc.: The company offers polymerase chain reaction (PCR) enzymes and reagents, inhibitors, and kits for various applications such as reverse transcriptase cloning, cDNA from an RNA template, and high-fidelity cloning.
F. Hoffmann-La Roche Ltd.: The company offers a range of molecular biology enzymes, kits, and reagents under its subsidiary Kapa Biosystems, Inc.
Illumina Inc.: The company offers a range of common molecular biology reagents such as ribosomal RNA removal reagents, DNA/RNA extraction kits, PCR reagents, and others.
Download our free sample report to get a brief understanding of various vendors and their strategies.
Key Market Drivers
Our analysts have extensively outlined the information on the key market drivers and their impact on the molecular biology enzymes, kits, and reagents market.
Pharmaceutical companies are increasing the use of proteins and reagents in the development of drugs for rare genetic disorders and diseases. For example, pharma companies are using glucose oxidase enzymes to detect the amount of glucose in the blood as an indicator for the diagnosis of diabetes. The increasing use of proteins and reagents in many such applications is expected to drive the growth of the market during the forecast period.
To know about a few other market drivers, trends, and challenges,
Download our free sample report
Related Reports:
Affinity Chromatography Reagents Market by End-user and Geography - Forecast and Analysis 2021-2025
Cell Culture Media and Reagents Market by End-user and Geography - Forecast and Analysis 2021-2025
Molecular Biology Enzymes, Kits, And Reagents Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 14.61% |
Market growth 2021-2025 |
USD 13.09 billion |
Market structure |
Fragmented |
YoY growth (%) |
14.30 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 39% |
Key consumer countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article